Jenny Holt

Senior Vice President, Programme and Portfolio Management • Ray Therapeutics

Jenny Holt, PMP is an experienced biotech and pharmaceutical executive with more than 25 years of experience primarily in gene therapies, ophthalmology, and oncolytic viral research. She is a graduate of UC Santa Barbara. Her first roles included scientist positions at UCSF Gladstone Institutes, Onyx Pharmaceuticals, and Novartis Institute of Biomedical Research. Most recently Jenny was head of project management at 4D Molecular Therapeutics, a leading AAV-based gene therapy company, where she managed five gene therapy products from discovery to early-stage clinical development. Jenny also was a co-founder/advisor at Ignite Immunotherapy which was purchased by Pfizer in 2019.

Also Speaking

Åsa Hagner Mcwhirter

Principal Scientist • Cytiva

Raisa Lowe

Vice President, Head of CMC and Quality • Arbor Biotechnologies

Stephen Sullivan

Founder • Lindville Bio

Also Speaking


Germfree Truck



Book your hotel room for your stay in Miami.